» Articles » PMID: 28376085

Status and Methodology of Publicly Available National HIV Care Continua and 90-90-90 Targets: A Systematic Review

Overview
Journal PLoS Med
Specialty General Medicine
Date 2017 Apr 5
PMID 28376085
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2014, the Joint United Nations Program on HIV/AIDS (UNAIDS) issued treatment goals for human immunodeficiency virus (HIV). The 90-90-90 target specifies that by 2020, 90% of individuals living with HIV will know their HIV status, 90% of people with diagnosed HIV infection will receive antiretroviral treatment (ART), and 90% of those taking ART will be virally suppressed. Consistent methods and routine reporting in the public domain will be necessary for tracking progress towards the 90-90-90 target.

Methods And Findings: For the period 2010-2016, we searched PubMed, UNAIDS country progress reports, World Health Organization (WHO), UNAIDS reports, national surveillance and program reports, United States President's Emergency Plan for AIDS Relief (PEPFAR) Country Operational Plans, and conference presentations and/or abstracts for the latest available national HIV care continuum in the public domain. Continua of care included the number and proportion of people living with HIV (PLHIV) who are diagnosed, on ART, and virally suppressed out of the estimated number of PLHIV. We ranked the described methods for indicators to derive high-, medium-, and low-quality continuum. For 2010-2016, we identified 53 national care continua with viral suppression estimates representing 19.7 million (54%) of the 2015 global estimate of PLHIV. Of the 53, 6 (with 2% of global burden) were high quality, using standard surveillance methods to derive an overall denominator and program data from national cohorts for estimating steps in the continuum. Only nine countries in sub-Saharan Africa had care continua with viral suppression estimates. Of the 53 countries, the average proportion of the aggregate of PLHIV from all countries on ART was 48%, and the proportion of PLHIV who were virally suppressed was 40%. Seven countries (Sweden, Cambodia, United Kingdom, Switzerland, Denmark, Rwanda, and Namibia) were within 12% and 10% of achieving the 90-90-90 target for "on ART" and for "viral suppression," respectively. The limitations to consider when interpreting the results include significant variation in methods used to determine national continua and the possibility that complete continua were not available through our comprehensive search of the public domain.

Conclusions: Relatively few complete national continua of care are available in the public domain, and there is considerable variation in the methods for determining progress towards the 90-90-90 target. Despite bearing the highest HIV burden, national care continua from sub-Saharan Africa were less likely to be in the public domain. A standardized monitoring and evaluation approach could improve the use of scarce resources to achieve 90-90-90 through improved transparency, accountability, and efficiency.

Citing Articles

Persistent advanced HIV disease in rural KwaZulu-Natal, South Africa: Trends, characteristics, and the urgent need for targeted interventions.

Kitenge M, Fatti G, Eshun-Wilson I, Nyasulu P PLoS One. 2025; 20(2):e0317674.

PMID: 39965033 PMC: 11835316. DOI: 10.1371/journal.pone.0317674.


A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV).

Raben D, Jakobsen M, Trajanovska J, Kowalska J, Vassilenko A, Dragas S PLoS One. 2025; 20(1):e0316794.

PMID: 39879174 PMC: 11778770. DOI: 10.1371/journal.pone.0316794.


Monitoring for advanced disease in the universal test and treat era: trends in CD4 count testing in South Africa.

Nattey C, Onoya D, Shumba K, Gareta D, MacLeod W, Fox M BMC Glob Public Health. 2025; 3(1):2.

PMID: 39748443 PMC: 11694356. DOI: 10.1186/s44263-024-00118-6.


Effects of alcohol on the composition and metabolism of the intestinal microbiota among people with HIV: A cross-sectional study.

Qiao N, Fang Q, Zhang X, Ke S, Wang Z, Tang G Alcohol. 2024; 120:151-159.

PMID: 38387693 PMC: 11383188. DOI: 10.1016/j.alcohol.2024.02.003.


Statistical methods applied for the assessment of the HIV cascade and continuum of care: a systematic scoping review.

Kalinjuma A, Glass T, Masanja H, Weisser M, Msengwa A, Vanobberghen F BMJ Open. 2023; 13(11):e071392.

PMID: 37996221 PMC: 10668296. DOI: 10.1136/bmjopen-2022-071392.


References
1.
Attia S, Egger M, Muller M, Zwahlen M, Low N . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009; 23(11):1397-404. DOI: 10.1097/QAD.0b013e32832b7dca. View

2.
Greenberg A, Hader S, Masur H, Young A, Skillicorn J, Dieffenbach C . Fighting HIV/AIDS in Washington, D.C. Health Aff (Millwood). 2009; 28(6):1677-87. DOI: 10.1377/hlthaff.28.6.1677. View

3.
Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S . Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. PMC: 4569751. DOI: 10.1056/NEJMoa1506816. View

4.
Supervie V, Marty L, Lacombe J, Dray-Spira R, Costagliola D . Looking Beyond the Cascade of HIV Care to End the AIDS Epidemic: Estimation of the Time Interval From HIV Infection to Viral Suppression. J Acquir Immune Defic Syndr. 2016; 73(3):348-355. DOI: 10.1097/QAI.0000000000001120. View

5.
Grinsztejn B, Hosseinipour M, Ribaudo H, Swindells S, Eron J, Chen Y . Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014; 14(4):281-90. PMC: 4144040. DOI: 10.1016/S1473-3099(13)70692-3. View